These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36160336)

  • 41. Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression.
    Azran C; Hanhan-Shamshoum N; Irshied T; Ben-Shushan T; Dicker D; Dahan A; Matok I
    Surg Obes Relat Dis; 2021 Jun; 17(6):1206-1217. PubMed ID: 33839048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia.
    Ge X; Zhu T; Zeng H; Yu X; Li J; Xie S; Wan J; Yang H; Huang K; Zhang W
    Biomed Res Int; 2021; 2021():8032978. PubMed ID: 34754882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.
    Gloy VL; Briel M; Bhatt DL; Kashyap SR; Schauer PR; Mingrone G; Bucher HC; Nordmann AJ
    BMJ; 2013 Oct; 347():f5934. PubMed ID: 24149519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement in pulmonary function in asthmatic patients after bariatric surgery: a systematic review and meta-analysis.
    Upala S; Thavaraputta S; Sanguankeo A
    Surg Obes Relat Dis; 2019 May; 15(5):794-803. PubMed ID: 30709751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.
    Arsenault BJ; Petrides F; Tabet F; Bao W; Hovingh GK; Boekholdt SM; Ramin-Mangata S; Meilhac O; DeMicco D; Rye KA; Waters DD; Kastelein JJP; Barter P; Lambert G
    J Clin Lipidol; 2018; 12(1):130-136. PubMed ID: 29103916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis.
    Peng W; Qiang F; Peng W; Qian Z; Ke Z; Yi L; Jian Z; Chongrong Q
    Int J Cardiol; 2016 Nov; 222():119-129. PubMed ID: 27494723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.
    Verma H; Garg R
    J Hum Nutr Diet; 2017 Oct; 30(5):621-633. PubMed ID: 28150351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Lowering Low-Density Lipoprotein Cholesterol with Contemporary Lipid-Lowering Medicines on Cognitive Function: A Systematic Review and Meta-Analysis.
    Ying H; Wang J; Shen Z; Wang M; Zhou B
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):153-166. PubMed ID: 32770521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials.
    Alomar SA; Găman MA; Prabahar K; Arafah OA; Almarshood F; Baradwan S; Aboudi SAS; Abuzaid M; Almubarki AAMA; Alomar O; Al-Badawi IA; Salem H; Abu-Zaid A
    Exp Gerontol; 2022 Mar; 159():111680. PubMed ID: 34973347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
    Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
    Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
    Schmidt AF; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011748. PubMed ID: 28453187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of randomized clinical trials comparing PCSK9 monoclonal antibody versus ezetimibe/placebo in patients at high cardiovascular risk.
    Ma W; Guo X; Ma Y; Hu Z
    Atherosclerosis; 2021 Jun; 326():25-34. PubMed ID: 34004550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis.
    Huang YT; Ho LT; Hsu HY; Tu YK; Chien KL
    Front Pharmacol; 2022; 13():832614. PubMed ID: 35444537
    [No Abstract]   [Full Text] [Related]  

  • 55. Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.
    Marcusa DP; Giugliano RP; Park JG; de Lemos JA; Cannon CP; Sabatine MS
    JAMA Cardiol; 2021 May; 6(5):582-586. PubMed ID: 33185670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cholesterol lowering with statins or proprotein convertase subtilisin/kexin type 9 antibodies on cataracts: A meta-analysis.
    Dobrzynski JM; Kostis JB; Sargsyan D; Zinonos S; Kostis WJ
    J Clin Lipidol; 2018; 12(3):728-733. PubMed ID: 29501393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robotic bariatric surgery for the obesity: a systematic review and meta-analysis.
    Zhang Z; Miao L; Ren Z; Li Y
    Surg Endosc; 2021 Jun; 35(6):2440-2456. PubMed ID: 33881624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysis.
    Farmakis I; Doundoulakis I; Pagiantza A; Zafeiropoulos S; Antza C; Karvounis H; Giannakoulas G
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):397-407. PubMed ID: 33298738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes.
    Marouf BH; Iqbal Z; Mohamad JB; Bashir B; Schofield J; Syed A; Kilpatrick ES; Stefanutti C; Soran H
    Clin Ther; 2022 Feb; 44(2):331-348. PubMed ID: 35246337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of bariatric surgery on the menstruation- and reproductive-related hormones of women with obesity without polycystic ovary syndrome: a systematic review and meta-analysis.
    Lv B; Xing C; He B
    Surg Obes Relat Dis; 2022 Jan; 18(1):148-160. PubMed ID: 34756568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.